Abstract:Chronic kidney disease (CKD) can be diagnosed by chronic deterioration in kidney function associated with renal parenchymal damage and may progress to end-stage renal disease (ESRD), [ 1 ] which has become a major public health concern. More than 800 million individuals are affected by CKD in 2017, and CKD was predicted to be the fifth leading cause of years of life lost. [ 2 , 3 ] CKD patients had higher mortality rates, [ 4 ] and CKD represents a major public health issue in Taiwan. Wen et al revealed that more than 10% of the Taiwanese population may be affected by CKD. [ 5 ] Comorbidities, such as cardiovascular disease (CVD) and congestive heart failure, not only exacerbate CKD progression but also impact the quality of life and mortality in CKD patients. [ 1 ] Common treatment options for ESRD patients include kidney transplantation and dialysis. [ 6 ] Despite advances in dialysis technology and cardiovascular therapies, cardiovascular-related mortality due to cardiac arrhythmias remains the largest cause of death among patients undergoing general dialysis. In ESRD patients treated with hemodialysis, the incidence of congestive heart failure had increased to 77.3% in 2021. [ 7 ] Given the high morbidity and mortality of these intertwined diseases, the use of hospice palliative care for patients with advanced CKD and CVD is critical to ensure that patients could make informed medical decisions and receive optimal treatment for their needs. Similar to CVD and congestive heart failure, the progression from pre-ESRD to ESRD is highly variable and can follow an unpredictable trajectory. [ 8 , 9 ] Consequently, it is important to understand the progression trajectory to properly initiate and integrate palliative care services, such as the management of patient symptoms and discussion of renal replacement therapy options, including dialysis and non-dialysis management for advanced CKD patients. [ 10 , 11 ] There are already numerous studies on the epidemiology and short-term survival of ESRD patients, [ 12–14 ] but the research on the long-term survival of non-cancer patients with advanced CKD is scarce. Machine learning (ML) has been applied successfully to different chronic diseases, such as chronic liver diseases, CVD, chronic obstructive pulmonary disease, and metabolic syndrome. [ 15–23 ] Furthermore, several studies in the past 2 years have utilized time-series ML techniques to predict the COVID-19 pandemic trend. [ 20 ] Previous studies also used unsupervised learning and network visualization of big data for chronic disease diagnoses. [ 24 ] Machine learning techniques were used in several research about renal problems such as CKD early detection in the EHR database or prediction for acute kidney injury. Several studies have been conducted on the use of artificial intelligence (AI) in ESRD and CKD. [ 20 , 25–29 ] However, these studies mostly focused on CKD prevention or identification. [ 21 , 30–33 ] For mortality prediction in ESRD patients, most studies have focused on populations with only kidney transplant therapy or hemodialysis. [ 34–36 ] Therefore, this study intends to construct a mortality prediction model with AI for pre-ESRD and ESRD patients.

Global forecasting of chronic kidney disease mortality rates and numbers with the generalized additive model

National trends and projection of chronic kidney disease incidence according to etiology from 1990 to 2030 in Iran: a Bayesian age-period-cohort modeling study

Predicting Cardiovascular Mortality in Chronic Kidney Disease (CKD) Patients.

Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019

Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019

Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014–2020 and forecasting future trends of prevalence and mortality for 2030

Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040

Abstract MP40: Global Burden of Chronic Kidney Disease in 2010: A Pooling Analysis of Population-Based Data Worldwide

Specific patterns and potential risk factors to predict 3-year risk of death among non-cancer patients with advanced chronic kidney disease by machine learning

The national trend of the burden of Chronic Kidney Disease (CKD) in Iran from 1990 to 2019

Global Burden of Chronic Kidney Disease in 2010: A Systematic Analysis of Population-Based Data Worldwide

An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease

Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study

Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the Global Burden of Disease Study 2019

Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study

Epidemiological analysis of chronic kidney disease from 1990 to 2019 and predictions to 2030 by Bayesian age-period-cohort analysis

Designing and Implementing an ANFIS Based Medical Decision Support System to Predict Chronic Kidney Disease Progression

Global disease burden attributable to kidney dysfunction, 1990-2019: A health inequality and trend analysis based on the global burden of disease study

Global incidence and death estimates of chronic kidney disease due to hypertension from 1990 to 2019, an ecological analysis of the global burden of diseases 2019 study

Development of Risk Prediction Equations for Incident Chronic Kidney Disease

Chronic Kidney Disease: Global Dimension and Perspectives